FDA Inspection
Atlantis Laboratories, IncAtlantis Laboratories, Inc – FDA Inspection, Jun 26, 2025
Record Details
This FDA Inspection record concerns Atlantis Laboratories, Inc, with an inspection on June 26, 2025, issued by the Dallas District Office, covering human drugs.
- Office
- Dallas District Office
- Person
View Company Profile
ID · f2d6e68d-d17e-4de1-a0e1-38d1d4c0a883
Inspection Facts
- Inspection number
- 1273885
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.80(d)Identification of Each Lot in Each Shipment
- 21 CFR 211.84(d)(2)Component written specification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Atlantis Laboratories, Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
| July 3, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 21, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 8, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Atlantis Laboratories, Inc
- FDA Inspection 1328476 - 2026-07-24
- FDA Inspection 1099349 - 2019-07-03
- FDA Inspection 953923 - 2015-10-21
- FDA Inspection 701546 - 2010-12-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.